SeaStar Medical Holding Corp
Develops therapies for critically ill patients with organ failure from hyperinflammation.
ICU | US
Overview
Corporate Details
- ISIN(s):
- US81256L1127 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 3513 BRIGHTON BLVD, 80216 DENVER
- Website:
- https://seastarmedical.com
- Sector:
- Manufacturing
Description
SeaStar Medical Holding Corp. is a commercial-stage medical technology company developing therapies for critically ill patients experiencing organ failure due to hyperinflammation. The company's primary product is the Selective Cytopheretic Device (SCD), a proprietary platform therapy designed to mitigate the effects of a dysregulated immune response, often called a cytokine storm. The SCD is an immunomodulatory device that selectively targets and neutralizes the most highly activated neutrophils and monocytes responsible for destructive inflammation. It is designed to integrate with existing hemodialysis systems to alter disease progression, reduce dependency on dialysis, and shorten stays in the intensive care unit for patients with conditions such as acute kidney injury.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SeaStar Medical Holding Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SeaStar Medical Holding Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SeaStar Medical Holding Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||